Dual-stack metabolic research blend. CagriSema-style protocol.
Product Information
- Compound: Cagrilintide + Semaglutide
- Category: Metabolic research
- Form: Lyophilized powder, single-use vial
Cagrilintide + Semaglutide: Mechanism & Published Research
This listing is a pre-blended vial combining cagrilintide, a long-acting amylin analogue, with semaglutide, a GLP-1 receptor agonist. The combination is studied as co-activation of amylin and GLP-1 pathways.
Published clinical research includes a phase 3a trial reported by Garvey and colleagues in the New England Journal of Medicine, which examined body-weight endpoints in adults with overweight or obesity.
The material sold here is not an authorized drug product. Trial findings relate to clinical trial material and do not describe the identity, purity or performance of a supplied research batch.
Canada Peptide Supply currently lists 2.5mg + 2.5mg and 5mg + 5mg blended lyophilized vials for laboratory research and analytical reference only. They are not intended for human or veterinary use.
Research use only: this information is provided for scientific reference. Canada Peptide Supply does not provide medical advice. Cagrilintide + Semaglutide is not approved by Health Canada for human consumption, diagnosis, treatment, or prevention of disease.
Batch documentation
Before ordering, contact us with the product name and selected size to ask which batch documentation is available. For an existing order, include the batch number on the label. Match any certificate to the exact batch and review the methods and results reported; a purity result alone does not establish sterility or suitability for human use. See our COA policy.
Shipping within Canada
Orders ship within Canada. Standard shipping is $24.99 CAD and express shipping is $49.99 CAD. Free standard shipping applies to a merchandise subtotal of $250 CAD or more; express shipping is not included. Review shipping, dispatch and returns before ordering. Transit estimates begin after dispatch.
Intended Use
This product is sold strictly for laboratory research, in-vitro testing, and analytical reference. It is not approved by Health Canada for human consumption, diagnosis, treatment, or prevention of disease. Buyer must be 21 years of age or older. By purchasing, you agree to our Terms of Sale.
Frequently asked about Cagrilintide + Semaglutide
What is Cagrilintide + Semaglutide studied for?
A blended amylin-analogue and GLP-1-agonist material used to study combined amylin and incretin signalling in controlled models. Research topics are not claims of clinical efficacy or directions for personal use.
Is this product intended for human use?
No. Cagrilintide + Semaglutide is sold strictly for laboratory research, in-vitro testing and analytical reference. It is not approved by Health Canada for human or veterinary use.
What is your refund policy?
Refunds, replacements and damaged-order claims follow our shipping, dispatch and returns policy.
Compare Cagrilintide + Semaglutide options
Select an option in the product selector to view its details and order. Prices and availability may change.
Reviews
There are no reviews yet.